Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

Active Trials

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Tasigna (nilotinib) / Novartis, Inhibikase

NCT01549548: Compassionate Use Ponatinib

No Longer Available

N/A

Ponatinib, AP24534

OHSU Knight Cancer Institute, Ariad Pharmaceuticals

Philadelphia Chromosome Positive (Ph+) Leukemias, Chronic Myeloid Leukemia

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites